Anne Lenz
Pediatric Endocrinology · St Petersburg, FLNPI 1093908048
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 252 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,392, more than ten times the $32 reported in 2019.
Across 252 payments — averaging $20.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$558
- Ascendis Pharma Endocrinology Inc$548
- Dexcom, Inc.$433
- Sanofi-aventis U.S. LLC$373
- Novo Nordisk$358
- Neurocrine Biosciences, Inc.$297
- plus $3K from 27 others
What the payments were for
- Food & beverage$5,224100%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $558 |
| Ascendis Pharma Endocrinology Inc | 25 | $548 |
| Dexcom, Inc. | 22 | $433 |
| Sanofi-aventis U.S. LLC | 16 | $373 |
| Novo Nordisk | 19 | $358 |
| Neurocrine Biosciences, Inc. | 12 | $297 |
| Eton Pharmaceuticals, Inc. | 3 | $287 |
| Pfizer | 12 | $233 |
| Insulet Corporation | 11 | $226 |
| Xeris Pharmaceuticals, Inc. | 12 | $217 |
| Azurity Pharmaceuticals, Inc. | 9 | $195 |
| Abbott | 10 | $189 |
| Tolmar Pharmaceuticals, Inc. | 12 | $152 |
| BETA Bionics, Inc. | 6 | $140 |
| Lifescan, Inc. | 7 | $133 |
| Medtronic | 3 | $126 |
| Tolmar, Inc. | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $93 |
| Endo USA, Inc. | 4 | $84 |
| Tandem Diabetes Care, Inc. | 4 | $81 |
| Kyowa Kirin, Inc. | 3 | $62 |
| Sanofi | 2 | $50 |
| Zealand Pharma US, Inc. | 2 | $43 |
| Sequel Med Tech, LLC | 2 | $42 |
| Rhythm Pharmaceuticals, Inc. | 2 | $37 |
| Endo Pharmaceuticals Inc. | 2 | $36 |
| Biomarin Pharmaceutical Inc. | 1 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| IBSA Pharma Inc. | 1 | $24 |
| Chiesi USA, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| EUSA Pharma (US) LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,250 in reported general payments places this provider in the 70th percentile of 102 pediatric endocrinology providers in Florida.
Other pediatric endocrinology in St Petersburg
- Joshua YangOrlando$846K
- Henry RodriguezTampa$211K
- Dorothy ShulmanTampa$104K
- Michael HallerGainesville$102K
- Alejandro DiazMiami$101K
- Samuel FreedmanPembroke Pines$71K
- Jennifer MillerGainesville$57K
- Miladys Palau CollazoPort St Lucie$54K
- Laura JacobsenGainesville$36K
- Matthew BensonOrlando$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.